OGD Reports Uptick in Generic Approvals for 2022

By PacConAdmin | February 28, 2023

The FDA’s Office of Generic Drugs (OGD) approved 742 abbreviated new drug applications (ANDA) in 2022 compared with 663 the previous year, according to OGD’s latest annual report.
Source: Drug Industry Daily

Posted in Drug Industry Daily